CY1117848T1 - Παραγωγα πολυμυξινης και χρησεις αυτων - Google Patents
Παραγωγα πολυμυξινης και χρησεις αυτωνInfo
- Publication number
- CY1117848T1 CY1117848T1 CY20161100502T CY161100502T CY1117848T1 CY 1117848 T1 CY1117848 T1 CY 1117848T1 CY 20161100502 T CY20161100502 T CY 20161100502T CY 161100502 T CY161100502 T CY 161100502T CY 1117848 T1 CY1117848 T1 CY 1117848T1
- Authority
- CY
- Cyprus
- Prior art keywords
- relates
- present
- polymyxin
- derivative
- gram
- Prior art date
Links
- 108010040201 Polymyxins Proteins 0.000 title abstract 4
- 239000003242 anti bacterial agent Substances 0.000 abstract 3
- 241000894006 Bacteria Species 0.000 abstract 2
- 206010029155 Nephropathy toxic Diseases 0.000 abstract 1
- 206010070834 Sensitisation Diseases 0.000 abstract 1
- 125000000539 amino acid group Chemical group 0.000 abstract 1
- 229940088710 antibiotic agent Drugs 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 125000002091 cationic group Chemical group 0.000 abstract 1
- 230000000295 complement effect Effects 0.000 abstract 1
- 230000007123 defense Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000007694 nephrotoxicity Effects 0.000 abstract 1
- 231100000417 nephrotoxicity Toxicity 0.000 abstract 1
- 230000007935 neutral effect Effects 0.000 abstract 1
- 229940041153 polymyxins Drugs 0.000 abstract 1
- 230000008313 sensitization Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
- C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
- C07K7/60—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation occurring through the 4-amino group of 2,4-diamino-butanoic acid
- C07K7/62—Polymyxins; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Engineering & Computer Science (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US83742606P | 2006-08-11 | 2006-08-11 | |
| DKPA200601055 | 2006-08-11 | ||
| PCT/FI2007/050441 WO2008017734A1 (en) | 2006-08-11 | 2007-08-10 | Polymyxin derivatives and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1117848T1 true CY1117848T1 (el) | 2017-05-17 |
Family
ID=39032653
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20161100502T CY1117848T1 (el) | 2006-08-11 | 2016-06-09 | Παραγωγα πολυμυξινης και χρησεις αυτων |
Country Status (21)
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060004185A1 (en) | 2004-07-01 | 2006-01-05 | Leese Richard A | Peptide antibiotics and peptide intermediates for their prepartion |
| FI20085469A0 (fi) * | 2008-02-08 | 2008-05-16 | Northern Antibiotics Oy | Polymyksiinijohdannaiset, joissa on lyhyt rasvahappohäntä, ja niiden käyttöjä |
| WO2010075416A1 (en) | 2008-12-23 | 2010-07-01 | Biosource Pharm, Inc. | Antibiotic compositions for the treatment of gram negative infections |
| US8415307B1 (en) | 2010-06-23 | 2013-04-09 | Biosource Pharm, Inc. | Antibiotic compositions for the treatment of gram negative infections |
| WO2012051663A1 (en) * | 2010-10-21 | 2012-04-26 | Monash University | Antimicrobial compounds |
| MX355217B (es) * | 2011-11-18 | 2018-04-10 | New Pharma Licence Holdings Ltd | Derivados de polimixina. |
| HUE059544T2 (hu) * | 2013-05-22 | 2022-11-28 | Spero Therapeutics Inc | Polimixin-származékok és ezek alkalmazása kombinációs terápiában különbözõ antibiotikumokkal |
| KR20160135739A (ko) * | 2014-03-11 | 2016-11-28 | 뉴 파마 라이센스 홀딩스 리미티드 | 폴리믹신 유도체 및 상이한 항생제와의 조합 요법에 있어서의 이들의 용도 |
| KR101664106B1 (ko) | 2014-09-11 | 2016-10-10 | 한국화학연구원 | 폴리믹신 b 화합물을 포함하는 심혈관 질환의 예방 및 치료용 약학적 조성물 |
| CN107108699A (zh) * | 2014-11-26 | 2017-08-29 | 新药物许可控股有限公司 | 化合物 |
| EP3233889B1 (en) | 2014-12-16 | 2022-07-06 | Shanghai MicuRx Pharmaceutical Co., Ltd. | Antimicrobial polymyxins for treatment of bacterial infections |
| HUE052575T2 (hu) * | 2014-12-18 | 2021-05-28 | Helperby Therapeutics Ltd | Új kombináció és alkalmazás |
| FI126143B (en) * | 2015-01-15 | 2016-07-15 | Northern Antibiotics Oy | Polymyxine derivative and its uses |
| US9763996B2 (en) | 2015-01-16 | 2017-09-19 | Northern Antibiotics, Ltd. | Polymyxin derivative and uses thereof |
| CN104672307B (zh) * | 2015-03-23 | 2017-09-29 | 吉林大学 | 一种提高阳离子短肽抗菌性和稳定性的方法 |
| EP3072956A1 (en) * | 2015-03-25 | 2016-09-28 | Université de Fribourg | Selective culture medium for polymyxin-resistant, gram-negative bacteria |
| FR3036406B1 (fr) | 2015-05-20 | 2019-07-19 | Biomerieux | Identification des bacteries resistantes aux carbapenemes par impermeabilite membranaire |
| WO2017083859A1 (en) * | 2015-11-12 | 2017-05-18 | The Trustees Of Columbia University In The City Of New York | Rational drug design targeting resistant gram-negative bacterial infections to polymyxin-class antibiotics |
| WO2017189868A1 (en) * | 2016-04-27 | 2017-11-02 | Spero Opco | Serine replacement polymyxin analogues useful as antibiotic potentiators |
| WO2017189866A1 (en) * | 2016-04-27 | 2017-11-02 | Spero Opco | Polymyxin analogs useful as antibiotic potentiators |
| GB201703898D0 (en) | 2017-03-10 | 2017-04-26 | Helperby Therapeautics Ltd | Method |
| GB201704620D0 (en) | 2017-03-23 | 2017-05-10 | Helperby Therapeautics Ltd | Combinations |
| WO2019084628A1 (en) * | 2017-11-02 | 2019-05-09 | The University Of Queensland | Peptide antibiotics |
| EP3560489A1 (en) * | 2018-04-27 | 2019-10-30 | European Molecular Biology Laboratory | Pharmaceutical compositions for prevention and/or treatment of infections and antibacterial-induced dysfunctions |
| DK3810633T3 (da) | 2018-06-25 | 2024-01-15 | Spero Therapeutics Inc | Forbindelser |
| WO2020018173A1 (en) * | 2018-07-19 | 2020-01-23 | Northeastern University | Compounds with antimicrobial properties |
| CN110179967A (zh) * | 2019-05-28 | 2019-08-30 | 中国医药集团总公司四川抗菌素工业研究所 | 多粘菌素母核和一种抗生素的组合物及其应用 |
| IT201900025414A1 (it) * | 2019-12-23 | 2021-06-23 | Univ Bologna Alma Mater Studiorum | Composto per il trattamento della sindrome emolitico uremica |
| WO2021150792A1 (en) | 2020-01-21 | 2021-07-29 | Micurx Pharmaceuticals, Inc. | Novel compounds and composition for targeted therapy of kidney-associated cancers |
| CN118028502B (zh) * | 2022-08-30 | 2024-07-26 | 四川大学华西医院 | 一类phoQ基因突变体、应用及其验证方法 |
| WO2024123712A1 (en) * | 2022-12-04 | 2024-06-13 | Genentech, Inc. | Analysis of candidate cytotoxic compositions |
| CN120399010B (zh) * | 2025-07-01 | 2025-09-12 | 杭州肽佳生物科技有限公司 | 抗生素多粘菌素的制备方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3450687A (en) | 1966-02-24 | 1969-06-17 | Pfizer & Co C | Lower alkanoyl esters of polymyxin antibiotics |
| JPS4915537B1 (cg-RX-API-DMAC10.html) | 1970-03-25 | 1974-04-16 | ||
| BE754411A (fr) | 1969-08-05 | 1971-02-04 | Rhone Poulenc Sa | Cyclopeptides derives des polymyxines et leur |
| GB2128617A (en) | 1982-10-06 | 1984-05-02 | Martti Vaara | Polypeptides for use in antibacterial therapy |
| PT1336611E (pt) * | 2000-11-20 | 2007-12-06 | Daiichi Sankyo Co Ltd | Compostos desalogenados |
| ATE500277T1 (de) | 2001-01-16 | 2011-03-15 | Univ Ramot | Hybridpeptide für die behandlung von bacteraemie und sepsis |
| DK1340506T3 (da) * | 2002-03-01 | 2007-05-07 | Chiesi Farma Spa | Sammensætninger omfattende pulmonære tensider og et polymyxin med forbedrede overfladeegenskaber |
| US20060004185A1 (en) | 2004-07-01 | 2006-01-05 | Leese Richard A | Peptide antibiotics and peptide intermediates for their prepartion |
-
2007
- 2007-08-10 BR BRPI0715095A patent/BRPI0715095B8/pt not_active IP Right Cessation
- 2007-08-10 NZ NZ575421A patent/NZ575421A/en not_active IP Right Cessation
- 2007-08-10 CN CN201310011979.8A patent/CN103059106B/zh not_active Expired - Fee Related
- 2007-08-10 KR KR1020147036680A patent/KR20150008198A/ko not_active Ceased
- 2007-08-10 CA CA 2694289 patent/CA2694289C/en active Active
- 2007-08-10 KR KR1020097004841A patent/KR101502453B1/ko not_active Expired - Fee Related
- 2007-08-10 CN CN200780029855.5A patent/CN101501063B/zh not_active Expired - Fee Related
- 2007-08-10 HR HRP20160552TT patent/HRP20160552T1/hr unknown
- 2007-08-10 RU RU2009107857/04A patent/RU2455311C2/ru active
- 2007-08-10 MX MX2009001398A patent/MX2009001398A/es active IP Right Grant
- 2007-08-10 DK DK07803704.1T patent/DK2057185T3/en active
- 2007-08-10 EP EP07803704.1A patent/EP2057185B1/en active Active
- 2007-08-10 HU HUE07803704A patent/HUE028271T2/en unknown
- 2007-08-10 JP JP2009523312A patent/JP5226685B2/ja not_active Expired - Fee Related
- 2007-08-10 PT PT07803704T patent/PT2057185E/pt unknown
- 2007-08-10 PL PL07803704.1T patent/PL2057185T3/pl unknown
- 2007-08-10 EP EP16168287.7A patent/EP3078672A1/en not_active Withdrawn
- 2007-08-10 AU AU2007283514A patent/AU2007283514B2/en not_active Ceased
- 2007-08-10 SI SI200731783A patent/SI2057185T1/sl unknown
- 2007-08-10 WO PCT/FI2007/050441 patent/WO2008017734A1/en not_active Ceased
- 2007-08-10 ES ES07803704.1T patent/ES2575521T3/es active Active
-
2009
- 2009-01-22 IL IL196693A patent/IL196693B/en active IP Right Grant
- 2009-02-12 NO NO20090674A patent/NO341982B1/no unknown
-
2012
- 2012-06-07 IL IL220270A patent/IL220270A0/en unknown
-
2016
- 2016-06-09 CY CY20161100502T patent/CY1117848T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2008017734A8 (en) | Polymyxin derivatives and uses thereof | |
| CY1118625T1 (el) | Παραγωγα πολυμυξινης με βραχεια ουρα λιπαρου οξεος και χρησεις αυτων | |
| CY1123052T1 (el) | Συνθεσεις και μεθοδοι σχετικες με παραλλαγες της πρωτεϊνες α (spa) | |
| CY1109970T1 (el) | Παραγωγα 6-11 δικυκλικου κετολιδιου | |
| BR112022001067A2 (pt) | Inibidores duplos de atm e dna-pk para uso em terapia antitumoral | |
| BR112012017269A2 (pt) | compostos heterocíclicos tricíclicos, composições e métodos de uso dos mesmos | |
| CY1119075T1 (el) | Αναστολεις κινασης mtor για ενδειξεις ογκολογιας και παθησεις που συσχετιζονται με την ατραπο mtor/p13k/akt | |
| CY1117766T1 (el) | Αντιβακτηριδιακα παραγωγα κινολινης | |
| CY1118347T1 (el) | Συνθετικα ανοσοενισχυτικα γλυκοπυρανοζυλο-λιπιδιων και συνθεσεις εμβολιων που τα περιεχουν | |
| CY1112708T1 (el) | [1η-ινδολο-5-υλο)-ετεροαρυλοξυ]-(1-αζα-δικυκλο[3.3.1]εννεανια ως χολινεργικοι συνδετες του ν-achr για την θεραπεια των ψυχωτικων και νευροεκφυλιστικων διαταραχων | |
| EA201990551A1 (ru) | Антибиотические соединения | |
| MX2009010059A (es) | Derivados de quinolina para el tratamiento de enfermedades inflamatorias. | |
| EA201692376A1 (ru) | Терапевтические конъюгаты с сульфатированными дендримерами для внутриклеточного нацеливания | |
| BR112012018954A2 (pt) | derivados de hetaril-[1,8]naftiridina | |
| BRPI0922220A8 (pt) | Uso de compostos antibacterianos, composição farmacêutica e combinação compreendendo os mesmos | |
| BRPI0715746B8 (pt) | composto ou sal farmaceuticamente aceitável do mesmo e composição farmacêutica os compreendendo | |
| CY1108834T1 (el) | Παραγωγα φθαλοκυανινης, διαδικασια παρασκευης τους, φαρμακευτικα σκευασματα που τις περιεχουν, και η χρηση τους | |
| BR112019007927A2 (pt) | conjugados de polimixina ? oligômeros de alginato | |
| TW200630374A (en) | Thiazolyldihydroindazoles | |
| NZ601262A (en) | Nucleic acid complexes | |
| BRPI1006626B8 (pt) | uso de um antibiotico fluoroquinolona para a produção de um medicamento para tratar uma infecção bacteriana pulmonar | |
| CY1112230T1 (el) | Αντιβακτηριακα παραγωγα κινολινης | |
| IL259289A (en) | Synthetic vaccines against streptoccocus pneumoniae serotype 2 | |
| FI2968427T3 (fi) | Konjugaatti sienisoluseinämän polysakkarideihin kohdentuvien vasta-aineiden indusoimiseksi | |
| CY1112027T1 (el) | Αντιβακτηριακα παραγωγα κινολινης |